1.
Long recovery from mass extinction seen
WASHINGTON, May 26 (UPI) -- The U.S. Food and Drug Administration has approved Samsca tablets (tolvaptan) to treat hyponatremia, an abnormally low concentration of sodium in the blood.
The FDA said it approved Samsca to treat hyponatremia associated with congestive heart failure, liver cirrhosi and the syndrome of inappropriate anti-diuretic hormone secretion.
The federal agency said Samsca helps raise sodium levels in the blood by removing extra body water in the urine. Patients using the drug in clinical trials had a greater degree of increase in sodium levels in the blood compared with patients taking a placebo.
Samsca is marketed by the Otsuka Pharmaceuticals Co. Ltd. of Tokyo.
|
|
|
|
|
|
| Additional Science News Stories | |
MIAMI, May 30 (UPI) --
The man who bit off parts of the face of a homeless man in Miami found his victim sleeping in the shade of elevated train tracks, video footage shows.
|
LOS ANGELES, May 30 (UPI) --
Actor Tim Daly said via Twitter his character Pete Wilder won't be on next season of the U.S. medical drama, "Private Practice."
|
ITHACA, N.Y., May 30 (UPI) --
The genome of the tomato has been decoded, a step toward improving yield, nutrition, disease resistance, taste and color of the tomato, U.S. researchers say.
|
TUCSON, May 30 (UPI) --
An Arizona woman said her 8-year-old daughter was humiliated to receive the "Catastrophe Award" from her teacher for giving the most homework excuses.
|
| Stories | Photos | People | Comments |
View Caption
